Evidence map›Paper›PMID 37705586›Full record

ArticleClinical case reports2023

Transformation of HHV-8-negative idiopathic multicentric Castleman disease into diffuse large B-cell lymphoma: A case report from Nepal.

Ashwini Gupta, Ayush Anand, Salman Haidar Hussain, Raju Shah, Rajesh Ranjan, Viplaw Subedi, Aastha Baral, Akshat Mishra, Anju Pradhan, Soniya Dulal

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ashwini GuptaBP Koirala Institute of Health Sciences Dharan Nepal.ORCID https://orcid.org/0000-0003-4142-2843
Ayush AnandBP Koirala Institute of Health Sciences Dharan Nepal.ORCID https://orcid.org/0000-0003-0279-4636
Salman Haidar HussainBP Koirala Institute of Health Sciences Dharan Nepal.
Raju ShahBP Koirala Institute of Health Sciences Dharan Nepal.
Rajesh RanjanDepartment of Internal Medicine BP Koirala Institute of Health Sciences Dharan Nepal.
Viplaw SubediDepartment of Internal Medicine BP Koirala Institute of Health Sciences Dharan Nepal.
Aastha BaralDepartment of Internal Medicine BP Koirala Institute of Health Sciences Dharan Nepal.
Akshat MishraDepartment of Internal Medicine BP Koirala Institute of Health Sciences Dharan Nepal.
Anju PradhanDepartment of Pathology BP Koirala Institute of Health Sciences Dharan Nepal.
Soniya DulalDepartment of Internal Medicine BP Koirala Institute of Health Sciences Dharan Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Idiopathic Castleman disease transforming into Diffuse Large B-cell Lymphoma has an aggressive course and can lead to mortality. Hence, early diagnosis and intervention are required. Abstract: Idiopathic Castleman disease transforming into non-Hodgkin lymphoma has an aggressive course, poor prognosis, and high mortality rate. Hence, early diagnosis and intervention are necessary. In a developing country like Nepal, where infectious diseases, particularly TB, are high, concomitant infection worsens the disease course. It also poses a diagnostic challenge as the clinical presentation may be similar.

Indexed as

case reportCastleman diseaseidiopathicmulticentricnon‐Hodgkin lymphoma

Identifiers

PMID37705586
PMCPMC10495613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.